Publications

• Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.

  (Chouliaras K, Senehi R, Ethun CG, Poultsides G, Tran T, Grignol V, Gamblin TC, Roggin KK, Tseng J, Fields RC, Weber SM, Russell GB, Levine EA, Cardona K, Votanopoulos K.) J Surg Oncol. 2019 Sep;120(3):340-347.

• RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.

  (Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN.) J Surg Res. 2019 Aug;240:130-135.

• It Is Time.

  (Turaga KK, Gamblin TC, Edwards R, Alexander HR, Bartlett D.) Ann Surg Oncol. 2019 Jul;26(7):1963-1966.

• Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative.

  (Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK.) Ann Surg Oncol. 2019 Jun 26.

• Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients.

  (Bliss LA, Strong EA, Gamblin TC.) J Surg Oncol. 2019 Apr;119(5):623-628.

• Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma.

  (Buettner S, Ten Cate DWG, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Pawlik TM, Koerkamp BG.) J Gastrointest Surg. 2019 Mar 18.

• Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival.

  (Robbins JR, Schmid RK, Hammad AY, Gamblin TC, Erickson BA.) Cancer Med. 2019 Mar;8(3):928-938.

• Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.

  (Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC.) J Am Coll Surg. 2019 Mar;228(3):245-254.

• Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

  (Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga KK.) JAMA Oncol. 2019 Feb 01;5(2):236-242.

• Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines.

  (Engelsgjerd S, Kunnimalaiyaan S, Kandil E, Gamblin TC, Kunnimalaiyaan M.) PLoS One. 2019;14(3):e0213776.

• Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative.

  (Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN.) J Surg Res. 2019 Jan;233:154-162.

• Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.

  (Yu PY, Beal EW, Hughes TM, Suarez-Kelly LP, Shelby RD, Ethun CG, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH.) J Surg Res. 2018 11;231:248-256.